Respiratory Real-World Evidence Strategy Lead

Ucb

Slough

Hybride

GBP 110 000 - 160 000

Plein temps

Il y a 7 jours
Soyez parmi les premiers à postuler

Une candidature complète en une minute

Un CV et une lettre de motivation personnalisés, prêts à envoyer.

Passez les filtres ATS

Résumé du poste

UCB is seeking a Real-World Evidence Strategy Lead for Respiratory, based in Slough, hybrid with 40% onsite. You will design and deliver global evidence strategies across development, regulatory decisions, market access, and safety to inform healthcare decisions.

The role requires a strong scientific background, leadership across teams, and collaboration with external experts and partners to drive impact and patient outcomes.

Qualifications

  • Advanced degree in life sciences, medicine, epidemiology, statistics, or a related discipline.
  • Eight years’ pharmaceutical industry experience, ideally within respiratory medicine or immunology.
  • Strong expertise in epidemiology, outcomes research, clinical development, regulation, and market access.
  • Experience developing integrated evidence strategies across multiple internal and external stakeholder groups.
  • Proven matrix leadership, influencing, mentoring, and cross-functional collaboration capabilities.
  • Excellent English communication and scientific writing skills, with strong quantitative expertise.

Responsabilités

  • Develop integrated real-world evidence strategies supporting respiratory assets throughout their lifecycle.
  • Translate stakeholder research questions into impactful data, registry, and evidence-generation plans.
  • Lead real-world evidence studies, ensuring quality, governance, timelines, and budget adherence.
  • Collaborate across functions to align evidence priorities and resolve competing stakeholder needs.
  • Build relationships with external experts, research partners, and healthcare decision-makers.
  • Mentor evidence-generation professionals and support capability development across the global function.

Connaissances

Epidemiology
Outcomes research
Clinical development
Regulatory affairs
Market access
Leadership
Cross-functional collaboration
Scientific writing
Data interpretation

Formation

Advanced degree in life sciences or related field

Description du poste

UCB is seeking a Real-World Evidence Strategy Lead for Respiratory, based in Slough, hybrid with 40% onsite. You will design and deliver global evidence strategies across development, regulatory decisions, market access, and safety to inform healthcare decisions.

The role requires a strong scientific background, leadership across teams, and collaboration with external experts and partners to drive impact and patient outcomes.

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Real-World Evidence Strategy Lead, Respiratory
Real-World Evidence Strategy Lead, Respiratory

Ucb • Slough

Hybride
GBP 110 000 - 160 000
Dermatology Real-World Evidence Strategy Lead
Dermatology Real-World Evidence Strategy Lead

Ucb • Slough

Hybride
GBP 75 000 - 110 000
Dermatology Real-World Evidence Strategy Lead — Hybrid
Dermatology Real-World Evidence Strategy Lead — Hybrid

UCB • Slough

Hybride
GBP 110 000 - 150 000
Real-World Evidence Strategy Lead, Dermatology (UK)
Real-World Evidence Strategy Lead, Dermatology (UK)

UCB • Slough

Hybride
GBP 110 000 - 150 000
Real-World Evidence Strategy Lead, Dermatology
Real-World Evidence Strategy Lead, Dermatology

Ucb • Slough

Hybride
GBP 75 000 - 110 000
RWE Strategy Lead, Developed Brands (UK)
RWE Strategy Lead, Developed Brands (UK)

UCB • Slough

Hybride
GBP 90 000 - 130 000
RWE Strategy Lead: Patient Impact & Access
RWE Strategy Lead: Patient Impact & Access

UCB • Slough

Hybride
GBP 90 000 - 130 000
RWE Strategy Lead, Developed Brands (UK)
RWE Strategy Lead, Developed Brands (UK)

UCB S.A. • Princes Risborough

Hybride
GBP 100 000 - 150 000
Global HEOR Strategy Lead, Payer & Value Insights
Global HEOR Strategy Lead, Payer & Value Insights

UCB S.A. • Slough

Hybride
GBP 90 000 - 130 000
Hybrid work model
Global exposure
Director, Respiratory RWE & Global Epidemiology
Director, Respiratory RWE & Global Epidemiology

Gsk • England

Hybride
GBP 140 000 - 170 000